• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

维生素D受体(VDR)对微小RNA的调控在不同前列腺细胞模型中存在差异,这表明转录调控具有极高的灵活性。

VDR regulation of microRNA differs across prostate cell models suggesting extremely flexible control of transcription.

作者信息

Singh Prashant K, Long Mark D, Battaglia Sebastiano, Hu Qiang, Liu Song, Sucheston-Campbell Lara E, Campbell Moray J

机构信息

a Departments of Pharmacology & Therapeutics ; Roswell Park Cancer Institute ; Buffalo , NY USA.

出版信息

Epigenetics. 2015;10(1):40-9. doi: 10.4161/15592294.2014.989088. Epub 2015 Jan 29.

DOI:10.4161/15592294.2014.989088
PMID:25494645
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4623602/
Abstract

The Vitamin D Receptor (VDR) is a member of the nuclear receptor superfamily and is of therapeutic interest in cancer and other settings. Regulation of microRNA (miRNA) by the VDR appears to be important to mediate its actions, for example, to control cell growth. To identify if and to what extent VDR-regulated miRNA patterns change in prostate cancer progression, we undertook miRNA microarray analyses in 7 cell models representing non-malignant and malignant prostate cells (RWPE-1, RWPE-2, HPr1, HPr1AR, LNCaP, LNCaP-C4-2, and PC-3). To focus on primary VDR regulatory events, we undertook expression analyses after 30 minutes treatment with 1α,25(OH)2D3. Across all models, 111 miRNAs were significantly modulated by 1α,25(OH)2D3 treatment. Of these, only 5 miRNAs were modulated in more than one cell model, and of these, only 3 miRNAs were modulated in the same direction. The patterns of miRNA regulation, and the networks they targeted, significantly distinguished the different cell types. Integration of 1α,25(OH)2D3-regulated miRNAs with published VDR ChIP-seq data showed significant enrichment of VDR peaks in flanking regions of miRNAs. Furthermore, mRNA and miRNA expression analyses in non-malignant RWPE-1 cells revealed patterns of miRNA and mRNA co-regulation; specifically, 13 significant reciprocal patterns were identified and these patterns were also observed in TCGA prostate cancer data. Lastly, motif search analysis revealed differential motif enrichment within VDR peaks flanking mRNA compared to miRNA genes. Together, this study revealed that miRNAs are rapidly regulated in a highly cell-type specific manner, and are significantly co-integrated with mRNA regulation.

摘要

维生素D受体(VDR)是核受体超家族的成员,在癌症和其他疾病环境中具有治疗意义。VDR对微小RNA(miRNA)的调控似乎对介导其作用很重要,例如控制细胞生长。为了确定在前列腺癌进展过程中VDR调控的miRNA模式是否以及在多大程度上发生变化,我们在7种代表非恶性和恶性前列腺细胞的细胞模型(RWPE-1、RWPE-2、HPr1、HPr1AR、LNCaP、LNCaP-C4-2和PC-3)中进行了miRNA微阵列分析。为了聚焦于VDR的主要调控事件,我们在用1α,25(OH)2D3处理30分钟后进行了表达分析。在所有模型中,111种miRNA受到1α,25(OH)2D3处理的显著调节。其中,只有5种miRNA在不止一种细胞模型中受到调节,而在这些miRNA中,只有3种在相同方向上受到调节。miRNA调控模式及其靶向的网络显著区分了不同的细胞类型。将1α,25(OH)2D3调控的miRNA与已发表的VDR ChIP-seq数据整合显示,VDR峰在miRNA侧翼区域显著富集。此外,对非恶性RWPE-1细胞的mRNA和miRNA表达分析揭示了miRNA和mRNA的共调控模式;具体而言,鉴定出13种显著的相互调控模式,并且在TCGA前列腺癌数据中也观察到了这些模式。最后,基序搜索分析揭示了与miRNA基因相比,mRNA侧翼VDR峰内的基序富集存在差异。总之,这项研究表明,miRNA以高度细胞类型特异性的方式被快速调控,并且与mRNA调控显著共同整合。

相似文献

1
VDR regulation of microRNA differs across prostate cell models suggesting extremely flexible control of transcription.维生素D受体(VDR)对微小RNA的调控在不同前列腺细胞模型中存在差异,这表明转录调控具有极高的灵活性。
Epigenetics. 2015;10(1):40-9. doi: 10.4161/15592294.2014.989088. Epub 2015 Jan 29.
2
Recruitment of NCOR1 to VDR target genes is enhanced in prostate cancer cells and associates with altered DNA methylation patterns.在前列腺癌细胞中,NCOR1 被募集到 VDR 靶基因,这与改变的 DNA 甲基化模式有关。
Carcinogenesis. 2013 Feb;34(2):248-56. doi: 10.1093/carcin/bgs331. Epub 2012 Oct 20.
3
Epigenetic distortion to VDR transcriptional regulation in prostate cancer cells.前列腺癌细胞中 VDR 转录调控的表观遗传扭曲。
J Steroid Biochem Mol Biol. 2013 Jul;136:258-63. doi: 10.1016/j.jsbmb.2012.10.002. Epub 2012 Oct 23.
4
Prostate cancer cell type-specific involvement of the VDR and RXR in regulation of the human PTHrP gene via a negative VDRE.维生素D受体(VDR)和视黄酸X受体(RXR)通过负性维生素D反应元件(VDRE)对人甲状旁腺激素相关蛋白(PTHrP)基因进行前列腺癌细胞类型特异性调控。
Steroids. 2006 Feb;71(2):102-15. doi: 10.1016/j.steroids.2005.08.009. Epub 2005 Oct 21.
5
Altered SMRT levels disrupt vitamin D3 receptor signalling in prostate cancer cells.SMRT水平的改变会破坏前列腺癌细胞中的维生素D3受体信号传导。
Oncogene. 2004 Sep 2;23(40):6712-25. doi: 10.1038/sj.onc.1207772.
6
The anti-proliferative effects of 1alpha,25(OH)2D3 on breast and prostate cancer cells are associated with induction of BRCA1 gene expression.1α,25(OH)₂D₃对乳腺癌和前列腺癌细胞的抗增殖作用与BRCA1基因表达的诱导有关。
Oncogene. 2000 Oct 19;19(44):5091-7. doi: 10.1038/sj.onc.1203888.
7
VDR microRNA expression and epigenetic silencing of vitamin D signaling in melanoma cells.VDR 微 RNA 表达与黑素瘤细胞维生素 D 信号的表观遗传沉默。
J Steroid Biochem Mol Biol. 2010 Jul;121(1-2):110-3. doi: 10.1016/j.jsbmb.2010.02.003. Epub 2010 Feb 11.
8
Epigenetic control of a VDR-governed feed-forward loop that regulates p21(waf1/cip1) expression and function in non-malignant prostate cells.非恶性前列腺细胞中维生素 D 受体调控的 p21(waf1/cip1) 表达和功能的前馈环的表观遗传控制。
Nucleic Acids Res. 2011 Mar;39(6):2045-56. doi: 10.1093/nar/gkq875. Epub 2010 Nov 17.
9
Dynamics of 1α,25-dihydroxyvitamin D3-dependent chromatin accessibility of early vitamin D receptor target genes.早期维生素D受体靶基因的1α,25-二羟基维生素D3依赖性染色质可及性动态变化
Biochim Biophys Acta. 2013 Dec;1829(12):1266-75. doi: 10.1016/j.bbagrm.2013.10.003. Epub 2013 Nov 1.
10
The human peroxisome proliferator-activated receptor delta gene is a primary target of 1alpha,25-dihydroxyvitamin D3 and its nuclear receptor.人类过氧化物酶体增殖物激活受体δ基因是1α,25-二羟基维生素D3及其核受体的主要作用靶点。
J Mol Biol. 2005 Jun 3;349(2):248-60. doi: 10.1016/j.jmb.2005.03.060. Epub 2005 Apr 7.

引用本文的文献

1
Discordant Health Implications and Molecular Mechanisms of Vitamin D in Clinical and Preclinical Studies of Prostate Cancer: A Critical Appraisal of the Literature Data.前列腺癌临床和临床前研究中维生素 D 不一致的健康影响和分子机制:对文献数据的批判性评价。
Int J Mol Sci. 2024 May 13;25(10):5286. doi: 10.3390/ijms25105286.
2
The Role of Estrogens and Vitamin D in Cardiomyocyte Protection: A Female Perspective.雌激素和维生素 D 在心肌细胞保护中的作用:女性视角。
Biomolecules. 2021 Dec 2;11(12):1815. doi: 10.3390/biom11121815.
3
Vitamin D-Induced Molecular Mechanisms to Potentiate Cancer Therapy and to Reverse Drug-Resistance in Cancer Cells.维生素 D 诱导的分子机制增强癌症治疗效果并逆转癌细胞的耐药性。
Nutrients. 2020 Jun 17;12(6):1798. doi: 10.3390/nu12061798.
4
Vitamin D Receptor Signaling and Cancer.维生素 D 受体信号与癌症。
Endocrinol Metab Clin North Am. 2017 Dec;46(4):1009-1038. doi: 10.1016/j.ecl.2017.07.007. Epub 2017 Sep 29.
5
MicroRNA biomarkers predicting risk, initiation and progression of colorectal cancer.预测结直肠癌风险、发病及进展的微小RNA生物标志物。
World J Gastroenterol. 2016 Sep 7;22(33):7389-401. doi: 10.3748/wjg.v22.i33.7389.
6
Pan-cancer analyses of the nuclear receptor superfamily.核受体超家族的泛癌分析
Nucl Receptor Res. 2015 Dec;2. doi: 10.11131/2015/101182. Epub 2015 Dec 15.
7
Vitamin D and Immune Response: Implications for Prostate Cancer in African Americans.维生素D与免疫反应:对非裔美国人前列腺癌的影响
Front Immunol. 2016 Feb 22;7:53. doi: 10.3389/fimmu.2016.00053. eCollection 2016.
8
Vitamin D: Metabolism, Molecular Mechanism of Action, and Pleiotropic Effects.维生素D:代谢、作用的分子机制及多效性作用
Physiol Rev. 2016 Jan;96(1):365-408. doi: 10.1152/physrev.00014.2015.

本文引用的文献

1
Nuclear receptors and the Warburg effect in cancer.核受体与癌症中的瓦伯格效应
Int J Cancer. 2015 Oct 1;137(7):1519-27. doi: 10.1002/ijc.29012. Epub 2014 Jun 16.
2
Patterns of genome-wide VDR locations.全基因组维生素D受体(VDR)定位模式。
PLoS One. 2014 Apr 30;9(4):e96105. doi: 10.1371/journal.pone.0096105. eCollection 2014.
3
Serum microRNA expression patterns that predict early treatment failure in prostate cancer patients.预测前列腺癌患者早期治疗失败的血清微小RNA表达模式。
Oncotarget. 2014 Feb 15;5(3):824-40. doi: 10.18632/oncotarget.1776.
4
Defective control of vitamin D receptor-mediated epithelial STAT1 signalling predisposes to severe respiratory syncytial virus bronchiolitis.维生素 D 受体介导的上皮 STAT1 信号通路缺陷控制易导致严重呼吸道合胞病毒细支气管炎。
J Pathol. 2014 Jan;232(1):57-64. doi: 10.1002/path.4267.
5
Cooperative behavior of the nuclear receptor superfamily and its deregulation in prostate cancer.核受体超家族的协同行为及其在前列腺癌中的失调。
Carcinogenesis. 2014 Feb;35(2):262-71. doi: 10.1093/carcin/bgt334. Epub 2013 Oct 8.
6
Circulating microRNAs predict biochemical recurrence in prostate cancer patients.循环 microRNAs 可预测前列腺癌患者的生化复发。
Br J Cancer. 2013 Aug 6;109(3):641-50. doi: 10.1038/bjc.2013.369. Epub 2013 Jul 11.
7
Identification of prostate cancer-associated microRNAs in circulation using a mouse model of disease.利用疾病小鼠模型鉴定循环中与前列腺癌相关的微小RNA
Methods Mol Biol. 2013;1024:235-46. doi: 10.1007/978-1-62703-453-1_19.
8
Circulating microRNAs as potential new biomarkers for prostate cancer.循环 microRNAs 作为前列腺癌潜在的新型生物标志物。
Br J Cancer. 2013 May 28;108(10):1925-30. doi: 10.1038/bjc.2013.192. Epub 2013 Apr 30.
9
A vitamin D receptor/SMAD genomic circuit gates hepatic fibrotic response.维生素 D 受体/SMAD 基因组回路调控肝纤维化反应。
Cell. 2013 Apr 25;153(3):601-13. doi: 10.1016/j.cell.2013.03.028.
10
Plasma miRNAs as biomarkers to identify patients with castration-resistant metastatic prostate cancer.血浆微小RNA作为鉴定去势抵抗性转移性前列腺癌患者的生物标志物
Int J Mol Sci. 2013 Apr 10;14(4):7757-70. doi: 10.3390/ijms14047757.